Skip to Main content Skip to Navigation
Conference papers

LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather

Abstract : no abstract
Document type :
Conference papers
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01162711
Contributor : Laurent Jonchère <>
Submitted on : Thursday, June 11, 2015 - 11:19:37 AM
Last modification on : Wednesday, September 2, 2020 - 3:22:55 AM

Identifiers

Citation

S. Pol, M. Bourlière, S. Lucier, V. de Ledinghen, F. Zoulim, et al.. LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather. The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S258--S259, ⟨10.1016/S0168-8278(15)30149-5⟩. ⟨hal-01162711⟩

Share

Metrics

Record views

685